Michel J Lebrun, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1111 Medical Center Blvd, North 504, Marrero, LA 70072 Phone: 504-349-6705 Fax: 504-347-0813 |
Judy C Kang, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1111 Medical Center Blvd, North 504, Marrero, LA 70072 Phone: 504-349-6705 Fax: 504-347-0813 |
Thomas H Grimstad, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1111 Medical Center Blvd, North 504, Marrero, LA 70072 Phone: 504-349-6705 Fax: 504-347-0813 |
William W Borron, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1111 Medical Center Blvd, North 504, Marrero, LA 70072 Phone: 504-349-6705 Fax: 504-347-0813 |
Elaine Lanasa, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1111 Medical Center Blvd, North 504, Marrero, LA 70072 Phone: 504-349-6705 Fax: 504-347-0813 |
News Archive
AstraZeneca and Rigel Pharmaceuticals Inc. today announced an exclusive worldwide license agreement for the global development and commercialization of R256, Rigel's inhaled JAK inhibitor shown to inhibit IL-13 and IL-4 signalling, which is being investigated as a treatment for moderate to severe chronic asthma. In preclinical research, R256 has been shown to reduce airway inflammation and improve lung function.
The Associated Press/Bloomberg Business: "The Senate failed Tuesday to repeal or ease an arcane tax reporting provision of the new health care law. ...Tucked into the health law is a requirement that businesses file tax forms called 1099s with the Internal Revenue Service for every vendor that sells them more than $600 in goods.
That pint of ice cream after a nasty breakup may not do as much damage as you think. Despite the emotional turmoil, people on average do not report gaining weight after a relationship dissolution, according to new research.
Baxter International Inc. today announced that the company has submitted a biologics license application to the United States Food and Drug Administration for approval of BAX 326, a recombinant factor IX (rFIX) protein being investigated for the treatment and prophylaxis of bleeding episodes for patients over 12 years of age with hemophilia B.
On Friday, April 16, from 2 - 5 p.m., the Barbara Ann Karmanos Cancer Center in Detroit will be conducting free oral, head and neck cancer screenings in conjunction with National Oral Head and Neck Cancer Awareness Week (April 12 – 18.) Some of the symptoms of oral cancer go unnoticed. A simple 10-minute screening exam can determine if there are problems and can help diagnose this disease in its early stage.
› Verified 1 days ago